Discover 533 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 533
Temsirolimus as Second-line Therapy in HCC
for
Unresectable or Metastatic Hepatocellular Carcinoma
Location: Memphis TN
Sponsor: University of Tennessee Cancer Institute
Sex: All
Age: 18+
Code: NCT01567930
Phase 2, Recruiting
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
for
Small Cell Lung Cancer
Location: Memphis TN, Zion IL, Tampa FL, Saint Paul MN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07531095
Phase 1, Recruiting
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for
Extensive Stage Small Cell Lung Cancer
Location: Memphis TN, St Louis MO, Louisville KY, Atlanta GA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037758
Phase 1, Recruiting
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
for
Small Cell Lung Cancer (SCLC),
Location: Memphis TN, Monroe LA, Louisville KY, Atlanta GA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07472517
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
for
Esophageal Squamous Cell Carcinoma
Location: Memphis TN, Nashville TN, Kansas City MO, Fort Worth TX,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06644781
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Memphis TN, Huntsville AL, Mobile AL, Atlanta GA,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase 3, Recruiting
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
for
Uterine Fibroids, Endometriosis
Location: Memphis TN, Jackson TN, Ridgeland MS, St Louis MO,
Sponsor: Sumitomo Pharma Switzerland GmbH
Sex: Female
Age: 18 - 50
Code: NCT05862272
Phase 3, Recruiting
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery